Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China

Research in Microbiology
Jin-Yan LiuMing-Jie Xiang

Abstract

This study was undertaken to characterize the mechanism(s) of azole resistance in clinical isolates of Candida albicans collected in Shanghai, China, focusing on the role of efflux pumps, target enzymes of fluconazole (Erg11), respiratory status and the ergosterol biosynthetic pathway. Clinical isolates of C. albicans (n = 30) were collected from 30 different non-HIV-infected patients in four hospitals in Shanghai. All 30 C. albicans isolates were susceptible to amphotericin B and 5-fluorocytosine. Twelve C. albicans isolates showed resistance to at least one type of triazole antifungal. Flow cytometry analysis of rhodamine 6G efflux showed that azole-resistant isolates had greater efflux pump activity, which was consistent with elevated levels of CDR1 and CDR2 genes that code for ABC efflux pumps. However, we did not observe increased expression of ERG11 and MDR1 or respiratory deficiency. Several mutations of ERG11 and TAC1 genes were detected. The F964Y mutation in the TAC1 gene was identified for the first time. Two main sterols, ergosterol and lanosterol, were identified by GC-MS chromatogram, and no missense mutations were found in ERG3. Furthermore, seven amino acid substitutions in ERG11, A114S, Y132H, Y132F, K143Q, K14...Continue Reading

References

Mar 21, 2002·The Lancet Infectious Diseases·Dominique Sanglard, Frank C Odds
May 23, 2002·Antimicrobial Agents and Chemotherapy·Theodore C WhiteDavid A Stevens
Sep 28, 2002·Biochimica Et Biophysica Acta·Eva J HelmerhorstFrank G Oppenheim
Sep 24, 2004·Diagnostic Microbiology and Infectious Disease·Gustavo H GoldmanArnaldo L Colombo
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Andrew S ChauPaul M McNicholas
Oct 6, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Steven Park, David S Perlin
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Sarah TsaoMartine Raymond
May 4, 2011·The Journal of Microbiology·Joon Kim, Peter Sudbery
Dec 12, 2012·The Journal of Antimicrobial Chemotherapy·Cen JiangYibing Peng
Mar 14, 2013·FEMS Yeast Research·Ming-Jie XiangHai-Liang Ge
Apr 2, 2013·The Journal of Antimicrobial Chemotherapy·Fengmei GuoUNKNOWN China-SCAN Team

❮ Previous
Next ❯

Citations

Jul 28, 2016·Future Medicinal Chemistry·Ann R HolmesRichard D Cannon
Jan 26, 2017·Frontiers in Pharmacology·Raafat El-AwadyGhada Elakraa
Dec 22, 2017·Antimicrobial Agents and Chemotherapy·Hassan E EldesoukyMohamed N Seleem
Nov 11, 2019·Journal of Applied Microbiology·F C RibeiroJ C Junqueira
Sep 22, 2020·Ecology and Evolution·Dorian J FeistelMeleah A Hickman
Aug 8, 2020·Frontiers in Microbiology·Jéssica Diane Dos SantosJuliana Campos Junqueira
Jun 6, 2018·Frontiers in Microbiology·Shankargouda PatilKamran H Awan
Feb 19, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Aina MesquidaPilar Escribano
May 27, 2021·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hongzhuo ShiHongxiang Lou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.